Epacadostat plus pembrolizumab in patients with advanced melanoma and select solid tumors: Updated phase 1 results from ECHO-202/KEYNOTE-037

被引：40

作者：

Gangadhar, T. C. ^{[1
]}

Hamid, O. ^{[2
]}

Smith, D. C. ^{[3
,4
]}

Bauer, T. M. ^{[5
]}

Wasser, J. S. ^{[6
]}

Olszanski, A. J. ^{[7
]}

Luke, J. J. ^{[8
]}

Balmanoukian, A. S. ^{[2
]}

Kaufman, D. R. ^{[9
]}

Zhao, Y. ^{[10
]}

Maleski, J. ^{[10
]}

Jones, M. J. ^{[10
]}

Leopold, L. ^{[10
]}

Gajewski, T. F. ^{[11
,12
]}

机构：

[1] Univ Penn, Abramson Canc Ctr, Div Hematol Oncol, Philadelphia, PA 19104 USA

[2] Angeles Clin & Res Inst, Res Dept, Los Angeles, CA USA

[3] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA

[4] Univ Michigan, Dept Urol, Ann Arbor, MI 48109 USA

[5] Tennessee Oncol, Sarah Cannon Res Inst, Drug Dev Unit, Nashville, TN USA

[6] Univ Connecticut, Ctr Hlth, Div Hematol & Med Oncol, Farmington, CT USA

[7] Fox Chase Canc Ctr, Dept Med Hematol Oncol, 7701 Burholme Ave, Philadelphia, PA 19111 USA

[8] Univ Chicago, Dept Med, Hematol Oncol Sect, Chicago, IL 60637 USA

[9] Merck & Co Inc, Oncol Clin Res, Kenilworth, NJ USA

[10] Incyte Corp, Drug Dev, Wilmington, DE USA

[11] Univ Chicago, Dept Pathol, 5841 S Maryland Ave, Chicago, IL 60637 USA

[12] Univ Chicago, Dept Med, Hematol Oncol Sect, Chicago, IL 60637 USA

来源：

关键词：

D O I：

10.1093/annonc/mdw379.6

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

1110PD

引用

页数：1